Da Qing Cai
Keine laufenden Positionen mehr
Profil
Da Qing Cai served as a Director at Bionano Genomics, Shenogen Pharma Group Ltd., and Berry Genomics Co., Ltd.
from 2016 to 2019.
Currently, he is an Independent Non-Executive Director at Jacobio Pharmaceuticals Group Co., Ltd.
Dr. Cai received his undergraduate degree from the University of Science & Technology of China in 1989, his doctorate from the University of California, Berkeley in 1996, and his graduate degree from Yale University in 1998.
Ehemalige bekannte Positionen von Da Qing Cai
| Unternehmen | Position | Ende |
|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 23.03.2023 |
| BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.08.2019 |
Shenogen Pharma Group Ltd.
 Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.03.2019 |
| BERRY GENOMICS CO.,LTD | Direktor/Vorstandsmitglied | 01.04.2018 |
Ausbildung von Da Qing Cai
| University of Science & Technology of China | Undergraduate Degree |
| Yale University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BERRY GENOMICS CO.,LTD | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shenogen Pharma Group Ltd.
Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Health Technology |
